These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
426 related items for PubMed ID: 19024175
1. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study. Zafar A, Hussain Z, Lomama E, Sibille S, Irfan S, Khan E. J Ayub Med Coll Abbottabad; 2008; 20(1):7-9. PubMed ID: 19024175 [Abstract] [Full Text] [Related]
2. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group. J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398 [Abstract] [Full Text] [Related]
3. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). Jacobs E, Dalhoff A, Korfmann G. Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763 [Abstract] [Full Text] [Related]
4. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15. Zafar A, Hasan R, Nizamuddin S, Mahmood N, Mukhtar S, Ali F, Morrissey I, Barker K, Torumkuney D. J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578 [Abstract] [Full Text] [Related]
8. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L. Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [Abstract] [Full Text] [Related]
10. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy]. Uncu H, Colakoğlu S, Turunç T, Demiroğlu YZ, Arslan H. Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256 [Abstract] [Full Text] [Related]
11. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values. Jones RN, Fritsche TR, Sader HS, Stilwell MG. Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903 [Abstract] [Full Text] [Related]
12. [The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2001 and 2002]. Melo-Cristino J, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias. Rev Port Pneumol; 2003 May; 9(4):293-310. PubMed ID: 19771688 [Abstract] [Full Text] [Related]
14. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents. Morrissey I, Colclough A, Northwood J. Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269 [Abstract] [Full Text] [Related]
18. Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States. Jamsheer A, Rafay AM, Daoud Z, Morrissey I, Torumkuney D. J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i45-61. PubMed ID: 27048582 [Abstract] [Full Text] [Related]